We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFIS icon
2526
Peoples Financial Services
PFIS
$707M
$17K ﹤0.01%
+371
New +$17.5K
PZZA icon
2527
Papa John's
PZZA
$806M
$17K ﹤0.01%
339
-5,651
-94% -$317K
SENEA icon
2528
Seneca Foods Class A
SENEA
$1.21B
$17K ﹤0.01%
648
-817
-56% -$22.9K
SJT
2529
San Juan Basin Royalty Trust
SJT
$118M
$17K ﹤0.01%
2,888
+970
+51% +$6.51K
SLP icon
2530
Simulations Plus
SLP
$371M
$17K ﹤0.01%
751
-4,413
-85% -$83.4K
BIG
2531
DELISTED
Big Lots, Inc.
BIG
$17K ﹤0.01%
403
-4,925
-92% -$207K
VIA
2532
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$17K ﹤0.01%
+355
New +$19.1K
MDLY
2533
DELISTED
Medley Management Inc
MDLY
$17K ﹤0.01%
467
+366
+362% +$17.5K
NBRV
2534
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$17K ﹤0.01%
20
+15
+300% +$17.2K
TECD
2535
DELISTED
Tech Data Corp
TECD
$17K ﹤0.01%
212
-1,147
-84% -$94.4K
STBZ
2536
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$17K ﹤0.01%
+505
New +$16.6K
FNBG
2537
DELISTED
FNB Bancorp Common Stock
FNBG
$17K ﹤0.01%
+455
New +$17K
LAC
2538
DELISTED
Lithium Americas Corp. Common Shares
LAC
$17K ﹤0.01%
3,220
-11,700
-78% -$63.9K
HRG
2539
DELISTED
HRG Group, Inc.
HRG
$17K ﹤0.01%
+1,324
New +$17.7K
AIRR icon
2540
First Trust RBA American Industrial Renaissance ETF
AIRR
$10.7B
$16K ﹤0.01%
+611
New +$16.1K
BL icon
2541
BlackLine
BL
$1.72B
$16K ﹤0.01%
+369
New +$15.6K
CASH icon
2542
Pathward Financial
CASH
$1.8B
$16K ﹤0.01%
+504
New +$18.3K
CGBD icon
2543
Carlyle Secured Lending
CGBD
$758M
$16K ﹤0.01%
952
+824
+644% +$14.7K
CHCO icon
2544
City Holding Co
CHCO
$2.04B
$16K ﹤0.01%
207
-308
-60% -$22.8K
CPIX icon
2545
Cumberland Pharmaceuticals
CPIX
$117M
$16K ﹤0.01%
2,669
+2,238
+519% +$14K
CRD.B icon
2546
Crawford & Co Class B
CRD.B
$604M
$16K ﹤0.01%
1,942
+1,211
+166% +$10K
CRUS icon
2547
Cirrus Logic
CRUS
$6.26B
$16K ﹤0.01%
415
-1,961
-83% -$75K
CTO
2548
CTO Realty Growth
CTO
$815M
$16K ﹤0.01%
976
+552
+130% +$9.12K
CTRN icon
2549
Citi Trends
CTRN
$605M
$16K ﹤0.01%
+588
New +$17.7K
DALN
2550
DELISTED
DallasNews
DALN
$16K ﹤0.01%
831
+342
+70% +$6.81K

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.